Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307
Saved in:
| Published in: | Rare Cancers and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552801626357761 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Rare Cancers and Therapy |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:61397 |
| institution | FRELIP |
| journal_source_facet | Rare Cancers and Therapy |
| last_indexed | 2026-06-20T21:26:42.861Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307 Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307 |
| title_alt | Tislelizumab de primera línea más quimioterapia para el cáncer de pulmón no microcítico escamoso avanzado o metastásico: seguimiento a largo plazo de 4 años de RATIONALE-307 Tislelizumab en première ligne associé à la chimiothérapie pour le cancer du poumon non à petites cellules épidermoïde avancé ou métastatique : suivi à long terme de 4 ans de RATIONALE-307 Tislelizumabe de Primeira Linha Mais Quimioterapia para Câncer de Pulmão de Células Não Pequenas Escamoso Avançado ou Metastático: Acompanhamento de 4 Anos de Longo Prazo do RATIONALE-307 |
| title_auth | First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307 |
| title_es_txt | Tislelizumab de primera línea más quimioterapia para el cáncer de pulmón no microcítico escamoso avanzado o metastásico: seguimiento a largo plazo de 4 años de RATIONALE-307 |
| title_fr_txt | Tislelizumab en première ligne associé à la chimiothérapie pour le cancer du poumon non à petites cellules épidermoïde avancé ou métastatique : suivi à long terme de 4 ans de RATIONALE-307 |
| title_full | First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307 |
| title_fullStr | First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307 |
| title_full_unstemmed | First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307 |
| title_pt_txt | Tislelizumabe de Primeira Linha Mais Quimioterapia para Câncer de Pulmão de Células Não Pequenas Escamoso Avançado ou Metastático: Acompanhamento de 4 Anos de Longo Prazo do RATIONALE-307 |
| title_short | First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307 |
| title_sort | first-line tislelizumab plus chemotherapy for advanced or metastatic squamous non-small cell lung cancer: 4-year long-term follow-up from rationale-307 |
| topic | Oncology General Oncology |
| url | https://link.springer.com/article/10.1007/s40487-026-00424-z |